ON THE SUBSTRATE CHARACTERISTICS OF 5-HYDROXYTRYPTAMINE-CERULOPLASMIN TREATED HUMAN FIBRIN EXPOSED TO FIBRINOLYTIC AGENTS.
D002275:Carcinoid Heart Disease; D002570:Ceruloplasmin; D003850:Deoxyribonuclease I; D005337:Fibrin; D005341:Fibrinolysin; D005342:Fibrinolysis; D005343:Fibrinolytic Agents; D006801:Humans; D008303:Malignant Carcinoid Syndrome; D010084:Oxidation-Reduction; D012106:Research; D012701:Serotonin; D012712:Serum Globulins; D013299:Streptodornase and Streptokinase; D013300:Streptokinase
D005343:Fibrinolytic Agents; D012712:Serum Globulins; D012701:Serotonin; D005337:Fibrin; D002570:Ceruloplasmin; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D005341:Fibrinolysin
CARCINOID HEART DISEASE; CERULOPLASMIN; EXPERIMENTAL LAB STUDY; FIBRIN; FIBRINOLYSIN; FIBRINOLYSIS; MALIGNANT CARCINOID SYNDROME; SEROTONIN; SERUM GLOBULINS; STREPTODORNASE AND STREPTOKINASE